By means of a simple mixing procedure, we have constructed cationic Sendai virosomes consisting of fusogenic viral F/HN proteins and cationic lipids. Sendai virus F/HN proteins were purified by Triton X-100 treatment and sequential centrifugation, and then quantitatively added to cationic liposomes. The presence of HN proteins is essential for hemolytic activity of Sendai virus as well as efficient gene transfection. The amount of detergent added for purification of F/HN proteins was also crucial for hemolytic activity. The relevance of F/HN proteins in the gene-transfer capability of the cationic Sendai F/HN virosomes (CSVs) was verified by heat inactivation of the F/HN proteins, and cell-binding competition. DNA condensation by protamine sulfate was able to further enhance the transfection efficiency and serum resistance of CSV. The enhanced transfection efficiency of protamine-condensed DNA-encapsulating cationic Sendai F/HN virosomes (PCSVs) may result from specific and efficient cell binding mediated by F/HN proteins and efficient DNA encapsulation by protamine. The DNA condensation by protamine was crucial for systemic in vivo gene transfer by CSVs. The PCSVs exhibited a higher gene expression in various organs, especially the liver, compared to DOTAP/Chol lipoplexes. These results demonstrate the potential for the use of PCSV as gene delivery vehicles for systemic gene transfer.
Introduction
During the last decade, numerous viral and nonviral vectors have been developed for efficient and safe gene delivery. In general, viral vectors provide higher transfection efficiency, although they may induce adverse immune responses, undesirable expression of viral genes and insertional mutagenesis. 1 In contrast, nonviral vectors including cationic liposomes are less toxic and less immunogenic and easily modified. 2, 3 However, they also have some shortcomings, including relatively low and transient gene expression. Thus, efficient gene transfer and sustained gene expression continue to be important targets of nonviral gene therapy. Recently developed gene expression cassettes containing elements for tissue-specific expression were able to express transgene products for more than a year. 4, 5 Cotransfection of transgenes with genes encoding enzymes inducing DNA integration into host genomes was also shown to be effective in inducing stable expression of the transgenes. 6 However, efficient gene transfer into intended cells is still a primary requisite for the efficient and sustained gene expression mediated by the newly developed nonviral systems.
A number of attempts have been made to enhance the efficiency of gene transfer by combining lipidic vectors and virus. One such attempt was the development of virosomes, liposomal vesicles incorporating viral fusogenic envelope proteins. Among the viral fusogenic proteins, Sendai viral envelope proteins have been the most frequently utilized in the preparation of virosomes as vehicles for gene delivery. The Sendai virus envelope contains two major glycoproteins; hemagglutinin-neuraminidase (HN) and fusion (F) proteins anchored in the outer leaflet of the viral lipid bilayers. 7, 8 It is known that the membrane fusion process mediated via F/HN proteins is initiated directly at the cell surface under the neutral pH conditions of the extracellular medium. 9, 10 Sendai virosomes are chimeric gene transfer system combining viral and nonviral features and have different characteristics and applications depending on the procedures employed in their preparation. The so-called HVJ (hemagglutinating virus of Japan)-liposomes can be prepared by incubation of UV-inactivated whole Sendai virus and negatively charged liposomes encapsulating plasmid DNA. 11, 12 The transfection efficiency and potential for clinical application of HVJ-liposomes have been evaluated at the cellular level and in various animal models. 12, 13 However, quality control issues resulting in difficulty in attaining a consistent level of gene expression, possible viral contamination and inefficient gene expression on systemic administration remain to be resolved before HVJ-liposomes will be suitable for clinical application.
14 Sendai F/HN virosomes prepared by quantitative reconstitution of Sendai F and HN proteins into liposomes encapsulating plasmid DNA may overcome the limitations of HVJ-liposomes. 15 We have developed a novel Sendai F/HN virosome system for in vivo gene transfection. The Sendai virosome formulations were optimized for in vitro and in vivo transfection, especially systemic gene delivery. We found that condensation of plasmid DNA by polycationic molecules, such as protamine sulfate (PS), provided additional enhancement of the in vivo gene-transfer capability of these virosomes. Cationic Sendai F/HN virosomes (CSVs) encapsulating condensed DNA can be utilized as nonviral vehicles for in vitro and in vivo gene transfer and subsequent transgene expression.
Materials and methods
Cell culture and DNA preparation HepG2 human hepatoblastoma, 293 human transformed kidney, HeLa human cervical adenocarcinoma and HRT-18 human colorectal adenocarcinoma cells were grown at 37 1C under a 5% CO 2 atmosphere in Dulbecco's Modified Eagle Medium, supplemented with 10% fetal bovine serum, 1 mM sodium bicarbonate, 50 mg ml À1 streptomycin and 500 U ml À1 penicillin. Plasmids encoding the green fluorescence protein (pEGFP-N1; Clontech, Mountain view, CA) and luciferase (pAAVCMV-Luc) were propagated in the DH5a strain of Escherichia coli in selective LB media supplemented with kanamycin (for pEGFP-N1) or ampicillin (for pAAVCMV-Luc). The plasmids were isolated and purified with a Qiagen Endo-free plasmid megaprep kit (Qiagen, Valencia, CA). The purity of plasmids was confirmed by 0.7% agarose gel electrophoresis followed by ethidium bromide staining and DNA quantification.
Sendai virus preparation
Sendai virus (ATCC no. 1698936, VR 907) was obtained from American Type Culture Collection (Manassas, VA) and was grown in the allantoic sac of 10-to 11-day-old embryonated chicken eggs. Diluted viral stocks in phosphate-buffered saline (PBS) containing 4-8 hemagglutinating units (HAU) were used to infect the eggs. The virus-infected eggs were incubated at 37 1C for 72 h and then left at 4 1C for 24 h. The allantoic fluid collected from the eggs was centrifuged at 3000 g for 30 min at 4 1C and the clear supernatant was collected. The virus in the supernatant was pelleted by centrifugation at 100 000 g for 1 h at 4 1C in an ultracentrifuge (Centrikon T-1180; Kontron Instruments, Milan, Italy). The virus pellet was resuspended in a small volume of PBS and finally dispersed with a teflon-coated tissue homogenizer. The concentration of viral proteins purified from the allantoic fluid was estimated by a Bio-Rad DC-protein assay kit (Bio-Rad Lab., Hercules, CA) using solution of bovine serum albumin (Sigma Chemical Co., St Louis, MO) as a standard. The purified virus was aliquoted in batches of 10 mg of protein and stored at À70 1C until further used. Hemagglutination activity of the harvested Sendai virus was titrated in 96-well microplates with 0.3-ml round bottom cups. The virus suspension was serially diluted twofold in 100 ml of PBS and then 100 ml of 1% human erythrocytes in PBS was added to each well. After incubation at 4 1C for 1 h, the HA titer was recorded as the reciprocal of the highest dilution showing positive HA and expressed as HAU per milliliter.
Purification of F and F/HN proteins Sendai F-and HN-proteins were purified as previously described with minor modifications. 16, 17 A suspension of 10 mg of Sendai virus in PBS was centrifuged at 100 000 g for 1 h at 4 1C. The pellet was resuspended in 2 ml of PBS containing 1% Triton X-100. After incubation at 20 1C for 2 h, the suspension was centrifuged at 100 000 g for 1 h at 4 1C to remove the detergent-insoluble substances presumably containing nucleocapsids. The detergent was removed from the clear supernatant by stepwise addition of SM2 Bio-Beads (Bio-Rad Lab.) with constant rocking. 18 Initially, the supernatant was incubated with 100 mg of methanol-washed SM2 Bio-Beads at room temperature. Two hours later, additional 100 mg of SM2 Bio-Beads were added to the reaction solution, which was further incubated at room temperature for 2 h. Another 200 mg of SM2 Bio-Beads were added and the incubation was terminated 2 h later. The turbid suspension was separated from the Bio-Beads using a 26-gauge needle. For purification of the F protein, the HN proteins were removed by dithiothreitol treatment before addition of Triton X-100. The virus pellet was resuspended in 4 ml of PBS containing 3 mM dithiothreitol. The suspension was incubated at 37 1C for 4 h and then dialyzed at 4 1C for 16 h against three changes of 1 l of PBS. The viral particles were centrifuged at 100 000 g for 1 h at 4 1C and the pellet was resuspended in 2 ml of PBS containing Triton X-100. After incubation at 20 1C for 2 h, the detergent was removed following the same procedure described above. The purified proteins were analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and stored at 4 1C.
Hemolysis assay
Human erythrocytes (RBCs) were washed three times with PBS and resuspended at a concentration of 1% (v/v) in PBS. Sendai virus concentrates (10 mg of Sendai virus in 2 ml) were treated with 0.25, 0.5, 1, 2 and 4% Triton X-100. The SM2 Bio-Beads were added to the order of 100 mg-100 mg-200 mg in 0.25, 0.5 and 1% Triton X-100, and 300 mg-300 mg-500 mg in 2, 4% Triton X-100. The RBC solution (0.3 ml) was mixed with the same volume of Sendai virus, virosomes or heat-inactivated virosomes prepared by a 20-min incubation at 56 1C. The assay mixture was incubated at 4 1C for 15 min and then at 37 1C for 1 h with occasional shaking. The reaction was terminated by chilling on ice and spinning at 11 000 g for 10 min in a microcentrifuge. The amount of hemoglobin released from RBCs was relatively compared by measuring optical density at 540 nm. The amount of hemoglobin released by addition of 1% Triton X-100 was considered as 100% hemolysis.
Preparation of cationic Sendai F/HN virosomes and protamine-condensed DNA-encapsulating cationic Sendai F/HN virosomes A mixture of DOTAP (1,2-dioleoyl-3-trimethylammonium propane) (Avanti polar lipids Inc., Alabaster, AL)/ Chol (cholesterol) (Sigma Chemical Co.) (10 mg, 5:5 molar ratio) was dissolved in 1 ml of chloroform/ methanol mixture (2:1, v/v). The lipid mixture was dried to a thin film under nitrogen gas and then vacuum desiccated for 1 h to remove residual traces of the organic solvent. The lipid film was then fully hydrated with 1 ml of distilled water. The resulting multilamellar vesicles were freeze-thawed 10 times and extruded 10 times through 100 nm pore diameter polycarbonate membranes using an Avanti Mini-Extruder (Avanti) The resulting cationic liposomes were stored at 4 1C and were used within 1 month after preparation. DNA-liposome complexes were prepared by gentle mixing of plasmids and the DOTAP/Chol liposome solution at various weight ratios of DNA/lipid. After incubation for 30 min at room temperature, various amounts of Sendai viral F/HN proteins (or F proteins) were added and incubation continued 15 min at room temperature with gentle mixing. The resulting complex is called CSVs. Protaminecondensed DNA-encapsulating cationic Sendai F/HN virosomes (PCSVs) were prepared by pre-complexation of plasmid DNA with various amounts of PS (Sigma Chemical Co.), followed by sequential addition of the DOTAP/Chol cationic liposomes and the purified F/HN proteins. The PCSVs for in vivo experiments were prepared by dropwise addition of PS to DNA with constant mixing to avoid aggregation.
Measurement of lipoplex size and z-potential
The size and z-potentials of DOTAP/Chol lipoplexes (1:12, wt ratio of DNA and lipid), CSVs (1:12:1, wt ratios of DNA, lipid and F/HN), and PCSVs (1:12:1:2, wt ratios of DNA, lipid, F/HN and PS) were measured using a Zetasizer (Zetasizer4, Malvern, UK). The lipoplex suspensions in deionized water were loaded into the capillary cell mounted on the zetasizer, and their size and z-potentials were measured five times per sample at 25 1C.
In vitro gene transfection
Tumor cells were seeded into 24-well plates and grown for 24 h at 37 1C. The CSVs or PCSVs (1:12 wt ratio of lipid and DNA) containing various amounts of the F/HN proteins were added to the cells (B80% confluency) in serum-free medium (1 mg DNA each well). The serum-free medium was replaced by cell culture medium 4 h later and the transfected cells were incubated for additional 24 h. To investigate the biological functions of the F/HN proteins in transfection, the CSVs were inactivated by heating at 56 1C for 20 min and then used for in vitro transfection. The in vitro transfection mediated by the CSVs was also done in the presence of 0.5 mg ml À1 asialofetuin (AF) (Sigma Chemical Co.) to examine whether AF is able to interfere with the gene-transfer function of the CSVs. The cells transfected with luciferase gene were then lysed with 200 ml of a lysis buffer (0.05% Triton X-100, 2 mM EDTA, 0.1 M Tris, pH 7.8).
Luciferase activities of the cell lysates (10 ml) were measured using a luciferase assay system (Promega, Madison, WI, USA) in a MultiLumat LB9506 luminometer (BG&G Berthold, BadWilbad, Germany). The luciferase activity of each sample was expressed as relative light units (RLU) per mg of extracted total proteins. Protein concentrations of the cell lysates were determined by the Bio-Rad DC protein assay (Bio-Rad). DNase I protection assay Plasmids (1 mg) encapsulated in CSVs or PCSVs were incubated in the presence of DNase I (0.05 Unit DNase per mg pDNA) (Sigma Chemical Co.) at 37 1C for 1 h. Two microliters of 0.5 M EDTA was immediately added to stop DNase I-induced degradation. Then, 2 ml of 1 M octylglucoside was added to lyse the virosomes. After incubation at room temperature for 20 min, 3 ml of 2% SDS was added, followed by additional incubation at room temperature for 20 min to release DNA from the complexes. Finally, the DNA samples were run on 0.7% agarose gel and the bands visualized with a UV illuminator (Fluor-S MultiImage; Bio-Rad).
Cell-binding assay
In vivo gene transfection CSVs (1:12, wt ratios of DNA and lipid) and PCSVs (1:12:1, wt ratios of DNA, lipid and PS) containing varied amounts of the F/HN proteins were prepared for animal experiments. Three female ICR mice (6-8 weeks old) (Daehan Biolink, Chungbuk, Korea) of each group were injected intravenously via the tail vein with the DOTAP/ Chol lipoplexes, CSVs or PCSVs (40 mg DNA in 300 ml of 2.5% w/v glucose-saline). Twenty-four hours post injection, the mice were anesthetized by subcutaneous injection of 2 0 2 0 2 0 -tribromoethanol (Sigma Chemical Co.), killed by cervical dislocation and the internal organs removed. The collected organs were homogenized in l ysis buffer (0.1 M Tris-HCl, 2 mM EDTA and 0.1% Triton X-100, pH 7.8) and the tissue mixtures were centrifuged at 11 000 g for 10 min at 4 1C. Finally, 10 ml of the supernatant was used for measurement of luciferase activity as described earlier. For histological analysis, the lungs and liver were dissected and immediately frozen. Cryosections (6 mm thick) were made using a LEICA CM 1510-cryostat (Leica, Nussloch, Germany). The sections were examined by fluorescence microscopy. At the same time, to view the areas of blood vessels in the liver, the retrieved sections were incubated in 0.5 mg ml À1 rabbit anti-vWF (von Willebrand factor) antibody (Chemicon, Temecula, CA) for 2 h. The primary antibody was detected using a Blood Vessel Staining Kit (Chemicon).
Results
Hemolytic activity of F and F/HN proteins purified by various amounts of Triton X-100 detergent F and HN proteins were purified from Sendai virus by membrane lysis with Triton X-100, a sequential centrifugation procedure, and removal of the Triton X-100 with SM2 Bio-beads. SDS-PAGE analysis of the purified protein mixture revealed relatively pure bands corresponding to F protein (45 kDa) and HN proteins (66 kDa) ( Figure 1a) . As indicated by a red blood cell hemolysis assay, hemolytic activity of the purified F/HN proteins was greater than that of whole Sendai virus at the same protein concentrations. However, the purified F proteins showed no hemolytic activity at all (Figure 1b) . The amount of Triton X-100 added to solubilize the viral envelope proteins was critical in maintaining fusogenic activity of the F/HN proteins. The F/HN proteins purified by treatment with 1% Triton X-100 exhibited higher hemolytic activity than those purified in any of the other concentrations of the detergent. Addition of Triton X-100 higher than 1% reduced the biological activity of F/HN proteins (Figure 1c) . Unexpectedly, treatment with Triton X-100 higher than 4% deprived the hemolytic activity of F/HN proteins (data not shown). To substantiate the role of F/HN proteins in gene transfection by the CSVs, the F/HN proteins were inactivated by incubation at 56 1C for 20 min and then used to prepare CSVs. Under the same transfection conditions, the CSVs containing heat-inactivated F/HN proteins exhibited threefold lower gene expression than the normal CSVs (Figure 3a) . In addition, competitive inhibition of the CSV binding to HepG2 cells by AF also supported the role of F/HN proteins in enhancing gene transfection. AF is a well-known ligand for asialoglycoprotein receptors (ASGP-Rs), which are known to be recognized by Sendai HN proteins. 19 Pretreatment of HepG2 cells with free AF significantly reduced CSVmediated gene transfection by 2.5-fold (Figure 3b Particle sizes and z-potentials of the CSVs and PCSVs, major parameters governing gene transfection activity, were also measured and compared (Table 1) . After completion of CSV and PCSV formation at a 1:12 wt ratio of pDNA and lipid, particle sizes and surface charges of the F/HN virosomes were compared with those of DOTAP/Chol lipoplexes. Addition of F/HN proteins little affected the vesicular size of the DOTAP/Chol lipoplex, but significantly reduced their positive surface potentials. However, pDNA condensation by PS addition slightly reduced the vesicular size of CSVs. These results indicate that the PCSVs form more compact and stable lipoplexes than the CSVs and that the PCSVs and CSVs are less positively charged than the DOTAP/Chol lipoplexes.
Effects of F/HN proteins on in vitro gene transfection

Specific cell binding and gene transfection capabilities of CSVs and PCSVs
The affinity of the Sendai virosomes for the HepG2 cell surface and consequent CSV-or PCSV-mediated expression of the GFP transgene were compared in parallel. The binding affinities and gene transfection efficiencies of the virosomal complexes were clearly dependent upon the presence of F/HN proteins. As determined by microscopic examination, cell-binding affinities of CSVs and PCSVs were similar to each other under the same experimental conditions (Figure 5a ). However, GFP expression induced by the PCSVs was higher than that by the CSVs. As expected, the cell-binding affinity and gene transfection efficiency of the DOTAP/Chol lipoplexes were much lower than those of both types of the Sendai virosomes. The binding of DOTAP/Chol lipoplexes to HepG2 cells became noticeable 6 h post treatment, while binding of the CSVs and PCSVs was clearly apparent after 3 h. Abbreviations: CSV, cationic Sendai F/HN virosome; PCSV, protamine-condensed DNA-encapsulating cationic Sendai F/HN virosome. a The lipoplex sizes and z-potentials were measured on a zetasizer at 25 1C.
Stability of CSVs and PCSVs in serum
b Mean values and standard deviations were calculated from five times measurements per sample.
injection. The group of mice administered with PCSVs prepared in a 1:12:0.25:1 ratio of DNA, lipid, F/HN protein and PS exhibited the highest gene expression in all the examined organs. Under the same experimental conditions, the PCSV induced 3-, 4-and 30-fold higher gene expression, respectively, in the kidney, lungs and liver than the DOTAP/Chol lipoplexes (Figure 7a) .
In vivo gene expression by the PCSV was also dependent on the amount of DNA administered and the ratios of PS, lipid and DNA. Increasing the amount of DNA led to a steady increase in gene expression in all the tissues examined. The minimum amount of DNA for maximal gene expression was found to be 40 mg per mouse (data not shown). The optimum DNA/lipid/PS wt ratios were found to be 1:12:1 (data not shown). Another set of mice were transfected with the GFP gene under the same transfection conditions above. Frozen sections of major organs of the mice transfected by DOTAP/Chol lipoplexes or PCSVs were examined by fluorescence microscopy. As expected, PCSV-mediated GFP expression in the liver was greater than that induced by the DOTAP/Chol-mediated lipoplexes (Figure 7b ). Interestingly, hepatic cells expressing GFP were easily detected in the PCSV-transfected mice, but not at all in mice transfected with the conventional lipoplexes. Careful examination after blood vessel staining verified that the cells expressing GFP were hepatocytes, neither endothelial cells nor macrophages (Figure 7c ).
Discussion
In recent years, remarkable progress has been made in the area of research on nonviral gene delivery and expression. The hydrodynamic transfection method has had a positive effect on gene expression mediated by nonviral plasmid vectors 20, 21 and newly developed tissue-specific gene expression cassettes redoubled that positive trend. 4 In addition, incorporation of Sleeping Beauty transposases or bacteriophage integrases into plasmid vectors enabled the transfer of therapeutic genes into host genomes, resulting in stable expression of the transgenes for the lifetime of the transfected cells. 22, 23 However, without efficient gene-transfer systems, the remarkable advantages of the gene expression systems would be for naught. Development of the PCSVs is a typical example of the efforts being made to provide efficient gene-transfer systems for nonviral gene therapy.
A key process for preparation of the Sendai virosomes was isolation of intact F/HN proteins from live Sendai virus. The Sendai F/HN proteins purified by treatment of Triton X-100 were as biologically active as those in live Sendai virus. The F protein alone had no hemolytic activity at all. This result substantiated that the HN protein is an essential component for fusogenic activity of Sendai viral F protein. 24 Interestingly, the biological activity of the isolated Sendai F/HN proteins was dependent on the concentration of Triton X-100 used to destabilize the viral membranes and solubilize the envelope proteins. The F/HN proteins treated with 4% or higher Triton X-100 exhibited significantly reduced hemolytic activity. This implies that lipid polymorphism surrounding the F/HN proteins is crucial for their biological functions. The reduced hemolytic or fusogenic activity of F/HN proteins may result from removal of lipid components crucial for proper reconstitution of the viral envelope proteins by excessive detergent treatment. It has been well documented that multiple components of influenza virus, measles virus and HIV are localized in low density, detergent-insoluble microdomains called lipid rafts. 25, 26 These lipid rafts play an important role in protein functional activity. Excessive detergent treatment may induce to break lipid raft essential for protein function.
The PCSVs exhibited superior in vitro transfection efficiency compared with conventional DOTAP/Chol lipoplexes in HepG2 cells, a human liver cancer cell line. However, the transfection enhancement by the F/HN proteins was not as great in nonhepatic cell lines, such as 293 transformed human kidney cells and HRT-18 human colorectal adenocarcinoma cells. Under the same transfection conditions, the optimized formulation of CSV exhibited an eightfold enhancement of transfection in HepG2 cells, but only 2.5-and 1.9-fold in 293 cells and HRT-18 cells, respectively. In in vivo transfection experiments, the PCSVs also demonstrated the greatest enhancement of gene expression than DOTAP/Chol and CSV in the liver, compared with the other examined organs. Presumably, these results imply that interactions of the Sendai virosomes with target cells are mediated via a specific receptor(s), highly expressed in the liver. Not only may the positively charged virosomal surface be beneficial for the initial interaction with the cell surface, but the specific association of F/HN proteins may also facilitate internalization of the virosomal complexes, presumably due to the fusogenic activity of these proteins.
It has been reported that Sendai virus efficiently uses two distinct receptors, sialic acid-containing gangliosides and ASGP-R. 27 ASGP-R is a hepatic receptor and is responsible for hepatic uptake. It has been demonstrated previously that F virosomes devoid of HN protein can specifically bind and fuse with HepG2 cells. 28 The target specificity of F virosomes was ensured by strong interaction between the terminal b-galactose moiety of the F protein and ASGP-R on the HepG2 cell membrane. ASGP-R also has terminal sialic acid moieties and therefore may also provide binding sites for the HN protein. The fusion rates of F/HN virosomes were threefold higher than those of F or HN virosomes binding separately to either the ASGP-R or to the terminal sialic acid receptor. However, on one hand, the purified F proteins had little hemolytic activity, while on the other, the F/HN protein mixture had potent hemolytic activity equivalent to intact Sendai virus. Meanwhile, gene transfection mediated by the F/HN protein/ASGP-R interaction was verified by inhibition of transfection with AF, a competitive inhibitor for ASGP-R. Addition of excess free AF was able to interfere with transfection mediated by the CSVs. This result implies that the enhanced gene transfer exhibited by the CSVs and PCSVs may be largely due to the specific interaction of the F/HN proteins with ASGP-R.
The optimized formulation of PCSVs provided better gene expression than those of CSVs or conventional DOTAP/Chol lipoplexes. DNA condensation with cationic polymers is widely applied to enhance gene transfection mediated by cationic liposomes, HVJ-liposomes. 29, 30 The addition of the F/HN proteins enhanced the in vitro transfection efficiency of DOTAP/Chol lipoplexes, but reduced somewhat their in vivo transfection efficiency in mice ( Figure 7a ). This data imply that the structural stability of CSVs containing F/HN proteins has to be further enhanced for their stable circulation in in vivo blood stream. DNA condensation with PS before addition of the F/HN proteins further enhanced the in vivo transfection efficiency of the CSVs, resulting in gene expression greater than that of the DOTAP/Chol lipoplexes. Stably condensed DNA might be more effectively encapsulated into the virosomal membranes, resulting in better protection of the DNA molecules from nuclease degradation. The better gene transfection of the PCSVs in the presence of serum as compared with that of the CSVs and the DOTAP/Chol lipoplexes may reflect the stabilization of the virosomal structure by protamine.
It has also been postulated that protamine containing 21 arginine residues (strongly basic) may function as a nuclear localization signal. 31 The cell-binding affinities of the PCSVs and CSVs appeared to be similar, but overall, the gene transfection efficiency of the PCSVs was higher than that of the CSVs. This also implies that DNA condensation by protamine may not affect the cellbinding affinity of the virosomes, but rather exerts its effect after internalizations, possibly as a nuclear localization signal.
Although a number of lipidic gene delivery systems have been developed for gene therapy, the in vivo transfection efficiency of these vectors has been poorly documented. 32, 33 After intravenous injection, the highest were intravenously administered to ICR mice via the tail vein. The mice were killed 48 h post injection, and major organs were collected and frozen sectioned. GFP expression of the sectioned liver was examined by fluorescence microscopy ( Â 100). (c) The sectioned liver tissues were also examined after S&E staining (upper) and blood vessel staining (middle) ( Â 100).
gene expression has been usually found in the lungs 34, 35 with some exceptions. 36 This high level of gene expression in the lungs is known to be due to easy capture of the lipoplexes in the first capillary bed of pulmonary vasculature due to the large particle size, compared with that of the capillary lumen. The PCSVs also exhibited their highest gene expression in the lungs. However, the PCSVs additionally showed elevated gene expression in the other organs as compared with the DOTAP/Chol lipoplexes. In particular, hepatic gene expression by the PCSVs was 30-fold higher than that by the conventional lipoplexes. As mentioned earlier, this enhanced hepatic gene expression can be related to the specific interactions of the Sendai F/HN virosomes with ASGP-R heavily expressed on the hepatic cell surface.
In summary, quantitatively prepared CSVs and PCSVs appear to be an efficient gene-transfer system and may be a superior alternative to conventional lipoplexes. Compared with other types of Sendai virosomes, they are more convenient to prepare and store. The quantitative preparation of these virosomes was able to provide consistent gene expression from batch to batch. Currently, examination of potential immune responses, which can be possibly induced by repetitive administration of the PCSVs has undertaken before further development of the virosomal vector. On the basis of the present observations, the PCSVs are potentially applicable to preclinical and clinical research in gene therapy. To develop the PCSVs in gene therapy.
